Statistics
Publications
6
Citations
162
H-Index
6
Active since
2022
Xin Ya See is an author at Harvard University specializing in immunotherapy, immune checkpoint inhibitors, and cancer immunotherapy.
Publications per year
2022–2025
6
6
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists
Albert Ko, Yu-Cheng Chang, Furkan Bahar et al. · Annals of Internal Medicine · 2025 · 13 citations
Medicine, Oncology, Pharmacology +14
Cho‐Han Chiang, Shao‐Hsuan Wang, Yeun‐Chung Chang et al. · Clinical Oncology · 2023 · 11 citations · Full text
1–5 of 6